David P Hochman, the See Remarks of $OBIO, bought 10,000 shares of the company on 03-13-2026 for an estimated $42,900. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 0.9%. Following this trade, they now own 1,086,467 shares of this class of $OBIO stock.
$OBIO Insider Trading Activity
$OBIO insiders have traded $OBIO stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $OBIO stock by insiders over the last 6 months:
- DAVID P HOCHMAN (See Remarks) has made 2 purchases buying 15,000 shares for an estimated $63,250 and 0 sales.
- JASON ARYEH purchased 1,000 shares for an estimated $2,450
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$OBIO Hedge Fund Activity
We have seen 38 institutional investors add shares of $OBIO stock to their portfolio, and 35 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PATHSTONE HOLDINGS, LLC removed 1,006,018 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $4,174,974
- KNOLL CAPITAL MANAGEMENT, LLC removed 455,128 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,888,781
- ALYESKA INVESTMENT GROUP, L.P. removed 365,482 shares (-26.8%) from their portfolio in Q4 2025, for an estimated $1,516,750
- DAFNA CAPITAL MANAGEMENT LLC removed 236,795 shares (-65.1%) from their portfolio in Q4 2025, for an estimated $982,699
- RENAISSANCE TECHNOLOGIES LLC removed 229,208 shares (-60.2%) from their portfolio in Q4 2025, for an estimated $951,213
- 683 CAPITAL MANAGEMENT, LLC added 204,076 shares (+inf%) to their portfolio in Q4 2025, for an estimated $846,915
- MARSHALL WACE, LLP added 171,681 shares (+inf%) to their portfolio in Q4 2025, for an estimated $712,476
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$OBIO Analyst Ratings
Wall Street analysts have issued reports on $OBIO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Cowen issued a "Buy" rating on 12/10/2025
- Chardan Capital issued a "Buy" rating on 11/13/2025
- Barclays issued a "Overweight" rating on 11/12/2025
To track analyst ratings and price targets for $OBIO, check out Quiver Quantitative's $OBIO forecast page.
$OBIO Price Targets
Multiple analysts have issued price targets for $OBIO recently. We have seen 3 analysts offer price targets for $OBIO in the last 6 months, with a median target of $15.0.
Here are some recent targets:
- Keay Nakae from Chardan Capital set a target price of $20.0 on 03/12/2026
- Matt Miksic from Barclays set a target price of $12.0 on 01/09/2026
- Joshua Jennings from TD Cowen set a target price of $15.0 on 12/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.